Popular on EntSun
- Top Edu-Tainment IP, Badanamu, enters children's mental health space, launching Healthy Kids Music Network - 449
- Jewellok Unveils Cutting-Edge Specialty Gas Changeover Manifolds to Revolutionize Industrial and Medical Gas Delivery - 443
- Buildout Unveils Rethink+: Revolutionizing Commercial Real Estate Prospecting with Seamless CRM Integration - 436
- HollyShorts Film Festival Celebrates 21 Years and selects '12 HOURS' For 2025 line-up - 427
- Final Clearance to Close Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA); $750 Million Ketamine Therapy Market - 423
- Vitanergy Health US Inc. Launches Three New Dietary Supplements to Support Women's Daily Wellness - 411
- Phinge®, Home of Netverse® and Netaverse™ With Verified and Safer AI Announces "Test the Waters" Campaign for Potential Regulation A+ Offering - 367
- EMBER™, the Only Standardized System Linking Workforce Identity to Growth, Appoints Global Brand Visionary Bret Sanford-Chung to Board of Directors - 360
- $3 Billion Suicidal Depression Market Advancements on Multiple Fronts, Highlighted by FDA Fast Track Designation for Effective NRX 100 Drug Therapy - 360
- Ubleu Crypto Group Achieves FinCEN Registration and Colorado Incorporation, Accelerating U.S. Market Entry - 339
Similar on EntSun
- The Learning Circle Childcare Centre – South Surrey Campus Currently Enrolling for September & Fall
- New Leadership Model – Never Fire Anyone – Released Today
- IOTAP Named to 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
- $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
- Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
- OddsTrader Projects Three Potential Elimination Games in Week 1 of College Football
- The Squires Group Becomes a Workday Partner
- 500% Increase in Revenue for Q2 with Acquisition Plans Including UK Telecom 3D Design/Modeling Company for Global AI Drone & Quantum Computing Leader
- K2 Integrity and Rafidain Bank Launch Strategic Partnership to Strengthen Financial Integrity
- Joint Venture for Expansion Into Asset-Backed Real Estate; $100 Million Initiative via Offering of Shares at Over $4 for Digital Assets: $OFAL
BioLab Holdings, Inc. Launches Its Largest Clinical Trial to Date Evaluating Human Placental Membrane Products
EntSun News/11066925
PHOENIX, July 31, 2025 ~ Phoenix-based medical manufacturer, BioLab Holdings, Inc., has announced the launch of its most comprehensive clinical trial to date. The trial, titled "A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers (BIOCAMP)," aims to evaluate the effectiveness of four human placental membrane (HPM) products in combination with standard of care (SOC) for treating nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).
The trial will enroll 650 participants across up to 30 clinical sites nationwide. According to Dr. Marshall Medley, chief medical officer at BioLab, this study marks a significant milestone in their commitment to advancing wound care through rigorous clinical research. He stated that by evaluating their full suite of amnion-based products in a real-world setting, they hope to provide clinicians with robust data to guide treatment decisions for patients with chronic wounds.
More on EntSun News
Participants will be randomly assigned to receive one of four BioLab products – Tri-Membrane Wrap™ (HPM-1), Membrane Wrap™ (HPM-2), Membrane Wrap-Lite™ (HPM-3), or Membrane Wrap-Hydro™ (HPM-4) – in addition to SOC or SOC alone. Treatments will be applied weekly for up to 12 weeks or until complete wound closure is achieved and confirmed two weeks later. Optional weekly visits will allow for dressing changes in both study arms.
The study is designed to capture real-world clinical outcomes and contribute to the growing body of evidence supporting the use of placental-derived allografts in chronic wound management. For more information on BioLab Holdings, Inc. and its regenerative wound care solutions, interested parties can visit their website at biolabholdings.net.
The trial will enroll 650 participants across up to 30 clinical sites nationwide. According to Dr. Marshall Medley, chief medical officer at BioLab, this study marks a significant milestone in their commitment to advancing wound care through rigorous clinical research. He stated that by evaluating their full suite of amnion-based products in a real-world setting, they hope to provide clinicians with robust data to guide treatment decisions for patients with chronic wounds.
More on EntSun News
- Where Are They Now Radio Show Celebrates 5-Year Anniversary on WCPT-820AM
- Brash Enterprises Launches Brash & Bold Future Speak YouTube Channel
- Integris Composites Joins Pacific Future Forum in Tokyo
- Brash Enterprises LLC Launches Brash & Bold Studios: A Minimalist Media Company for Unfiltered Storytelling
- Artest Management Group Celebrates Successful Launch at LA Creator Space
Participants will be randomly assigned to receive one of four BioLab products – Tri-Membrane Wrap™ (HPM-1), Membrane Wrap™ (HPM-2), Membrane Wrap-Lite™ (HPM-3), or Membrane Wrap-Hydro™ (HPM-4) – in addition to SOC or SOC alone. Treatments will be applied weekly for up to 12 weeks or until complete wound closure is achieved and confirmed two weeks later. Optional weekly visits will allow for dressing changes in both study arms.
The study is designed to capture real-world clinical outcomes and contribute to the growing body of evidence supporting the use of placental-derived allografts in chronic wound management. For more information on BioLab Holdings, Inc. and its regenerative wound care solutions, interested parties can visit their website at biolabholdings.net.
Filed Under: Business
0 Comments
Latest on EntSun News
- AureaVault Launches U.S.-Licensed Cryptocurrency Exchange with Enhanced Security Features
- IOTAP Named to 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
- Melanie Georgiou Unleashes Summer Anthem "Sunshine" Featuring Oscar
- Lineus Medical and Venture Medical Sign New Zealand Distribution Agreement
- Calling All Music Lovers! Get ready to Celebrate One-Hit Wonder Day with Big Bucks & Run For Office
- Black Plumbing Expands to Cleburne, TX, Bringing Over 30 Years of Trusted Plumbing Service
- PhingePlay Magnetically Connectable Foldable 1 2 & 3 Screen Wireless 1 or 2 Player Gaming Systems Can Be Created By Using Any Patented Phinge Phone
- $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
- New Book: Cold War Sci-Fi Thriller Arrives Today
- BeeCool Bikes Unveils Next-Generation "Super Frame" with Bee Defender Series
- Elklook Redefines Eyewear: Beyond Fashion, Creating Value
- University of South Pacific and Battery Pollution Technologies Forge Strategic Partnership to tackle Battery End-of-Life Challenges in the Pacific
- Shincheonji Tanzania Church Holds Revelation Bible Exam with Local Pastors and Believers
- Pro DJs Australia: Sydney's Multi-Award Winning DJ Service Elevates Event Entertainment
- Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
- Phinge's® One-Of-A-Kind Modular Earbuds With Stylish Interchangeable Battery Modules & Dual Charging Case Available Soon for Pre-Sale
- Victoria Carson's Powerful Anthems of Justice!
- Growth Acceleration via Strategic Reverse Split After $10 Million Acquisition for Concerts.com and TicketStub.com; AI Powered Sports/Entertainment Co
- OddsTrader Projects Three Potential Elimination Games in Week 1 of College Football
- Century Fasteners Corp. Exhibiting at the 2025 International Fastener Expo